Geriatrics in the Intensive Care Unit
Launched by HOSPITAL DEPARTAMENTAL DE VILLAVICENCIO · May 23, 2025
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Geriatrics in the Intensive Care Unit," aims to better understand the health outcomes of older adults who are admitted to intensive care units (ICUs). As more older individuals are being treated in these units, the researchers want to gather important information about their experiences, including how long they stay in the ICU, whether they need help breathing with machines, and the overall chances of recovery. The study will compare three different age groups: those under 65 years, those between 65 and 79, and those aged 80 and above.
To participate in this study, individuals must be over 18 years old and have been discharged from the ICU. There are no specific exclusions, meaning almost anyone in this age range who has been in the ICU can be considered. While the study is not yet recruiting participants, it will provide valuable insights into the care and outcomes of older patients in critical situations, helping to improve treatment and support for this growing population.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Registry of adults older than 18 years, discharged from the critical care unit.
- Exclusion Criteria:
- • None.
About Hospital Departamental De Villavicencio
The Hospital Departamental de Villavicencio is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care, the hospital plays a pivotal role in the development of new therapies and treatment protocols. By fostering collaboration among healthcare professionals, researchers, and regulatory bodies, the hospital aims to contribute to the scientific community while ensuring the highest standards of safety and ethical practices in clinical research. Its diverse patient population and state-of-the-art facilities make it an ideal setting for conducting impactful clinical studies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Villavicencio, Meta, Colombia
Patients applied
Trial Officials
Norton Perez, MD
Principal Investigator
Hospital Departamental de Villavicencio
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported